Limited coverage drugs – granisetron
Last updated on August 27, 2024
|
Generic name |
granisetron |
|---|---|
|
Strength |
1 mg, 1 mg/mL |
|
Form |
tablet, vial |
|
Special Authority criteria |
Approval period |
|---|---|
| Prevention and treatment of nausea and vomiting associated with chemotherapy | First approval: 6 months
Renewals: 6 months |
Practitioner exemptions
Practitioners in the following specialties are not required to submit a Special Authority request for coverage:
- oncologist (medical)
- oncologist (radiation)
Special notes
- None
Special Authority requests